Mingxiang Xie — Guangzhou University of Chinese Medicine

Area of research

Endocrinology, Diabetes and Metabolism · Molecular Biology

Research interest

Research focused on Mechanism (biology) and Psoriasis, with related work in Pharmacology, Isoliquiritigenin, Efflux. Notable publications include 'Assessing the Anti‐inflammatory Mechanism of Reduning Injection by Network Pharmacology', 'Molecular mechanism of PSORI-CM01 for psoriasis by regulating the inflammatory cytokines network', and '(+/−)-Borneol Reverses Mitoxantrone Resistance against P-Glycoprotein'.

Recent publications

Multi-Target Mechanism of Compound Qingdai Capsule for Treatment of Psoriasis: Multi-Omics Analysis and Experimental Verification

Drug Design Development and Therapy 2025cited by 8position: middledoi

Molecular mechanism of PSORI-CM01 for psoriasis by regulating the inflammatory cytokines network

Journal of Ethnopharmacology 2023cited by 12position: firstdoi

Pathway network-based quantitative modeling of the time-dependent and dose-response anti-inflammatory effect of Reduning Injection

Journal of Ethnopharmacology 2023cited by 3position: middledoi

Molecular Mechanism of Psori-Cm01 for Psoriasis by Regulating the Inflammatory Cytokines Network

SSRN Electronic Journal 2023cited by 3position: firstdoi

Assessing the Anti‐inflammatory Mechanism of Reduning Injection by Network Pharmacology

BioMed Research International 2020cited by 16position: middledoi

(+/−)-Borneol Reverses Mitoxantrone Resistance against P-Glycoprotein

Journal of Chemical Information and Modeling 2020cited by 9position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Endocrinology, Diabetes and Metabolism · Molecular Biology →